Publications by authors named "G Beaton"

Claim this Profile
T
The PD COMM Process Evaluation: Describing Interventions and Implementation in a UK Pragmatic Randomised Controlled Trial of Speech and Language Therapy for People With Parkinson's-Related Dysarthria.
Avril Nicoll, Marian C Brady, Patricia Masterson-Algar, Christopher Burton, Gillian Beaton

Int J Lang Commun Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.
Catherine M Sackley, Caroline Rick, Marian C Brady, Christopher Burton, Sue Jowett, Gillian Beaton

Health Technol Assess· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.
Catherine M Sackley, Caroline Rick, Marian C Brady, Rebecca Woolley, Christopher Burton, Gillian Beaton

BMJ· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH models.
Jashdeep Bhattacharjee, Graham Beaton, Satheesh B Ravula, Suk Joong Lee, Kevin B Bacon

Hepatol Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 Model.
Nadine Abi-Jaoudeh, Ben Sadeghi, Hanna Javan, Jim Na, Graham Beaton

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis